TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer

NCT05993702 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

TAS 102
Regorafenib
Fruquintinib
Gastrointestinal Tumours

Interventions

DRUG: regorafenib
DRUG: fruquintinib

Sponsor

China Medical University, China